Date of publication: 2017-09-04 03:15
As brain injury vision rehabilitation becomes more commonplace, the need for optometrists trained in this area is increasing. This article discusses inpatient vs. outpatient delivery of care, diagnoses, assessment and treatment for patients who have acquired brain injuries.
Departmental curricula leading to the bachelor’s degree include actuarial sciences, biomedical sciences, biochemistry, chemistry, clinical laboratory and medical sciences, geography, geology, microbiology, molecular biology, marine biology, mathematics, applied mathematics, organismal biology, and physics.
Now, let's take a look at some of the most common ocular conditions you will see in ABI/TBI patients and talk about what to look for and how to treat it. ( See "Acquired Brain Injury Diagnoses," below. )
More obscure vision errors, known as higher-order aberrations , also are related to flaws in the way light rays are refracted as they travel through the eye's optical system.
As caring providers, we want to have the knowledge to offer our patients the newest and most effective treatments available for their visual dysfunction. I will discuss inpatient vs. outpatient delivery of care, diagnoses, assessment and treatment for the ABI patient. Currently there is no consensus on the best model for BIVR care, and there is no evidence to support one method over another.
The process of vision begins when light rays that reflect off objects and travel through the eye's optical system are refracted and focused into a point of sharp focus.
These types of vision errors, which can create problems such as poor contrast sensitivity , are detected through new technology known as wavefront analysis.
It is possible to concentrate brolucizumab up to 675 mg/mL, allowing the administration of 6 mg in a single 55-mL IVT injection. On a molar basis, 6 mg of brolucizumab equals approximately 67 times the -mg dose of aflibercept and 77 times the -mg dose of ranibizumab. Thus this drug has potential advantages in the treatment of ARMD. Assuming comparable half-life, higher molar doses of drug may be cleared more slowly from the eye, thus prolonging duration of action. Small molecular weight + higher molar doses + high drug concentration gradient between the vitreous and retina may support support superior drug distribution into the retina.